Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cytori Therapeutics to Webcast Third Quarter Financial Results and Provide a Business Update on November 14, 2006.


SAN DIEGO -- Cytori Therapeutics, Inc., (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:CYTX) (Frankfurt:XMPA XMPA X-ray Electron Microprobe Analysis
XMPA Extensible Media Protection Architecture
) announced today it will release financial results for the nine months ended September 30, 2006 on Tuesday, November 14, 2006 at approximately 4:00 p.m. Eastern Standard Time (EST EST electroshock therapy.

EST
abbr.
electroshock therapy
). The company's management will host a conference call at 4:30 p.m. (EST) to discuss the results.

The audio webcast may be accessed under "Events & Webcasts" in the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 section of the Company's website at http://www.cytoritx.com. The webcast will be available live and by replay two hours after the call on the company's website and archived for 14 days. A telephone replay will be available for one week. To access the replay, please call +1 (303) 590-3000 (PIN: 11072851#).

About Cytori Therapeutics

Cytori Therapeutics, Inc., (NASDAQ:CYTX) (Frankfurt:XMPA) is discovering and developing proprietary cell-based therapeutics utilizing adult stem and regenerative cells derived from adipose tissue adipose tissue (ăd`əpōs'): see connective tissue.
adipose tissue
 or fatty tissue

Connective tissue consisting mainly of fat cells, specialized to synthesize and contain large globules of fat, within a
, also known as fat. The Company's investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose adipose /ad·i·pose/ (ad´i-pos)
1. fatty.

2. the fat present in the cells of adipose tissue.


ad·i·pose
adj.
Of, relating to, or composed of animal fat; fatty.
 stem and regenerative cells, Cytori has developed its proprietary Celution[TM] System to isolate and concentrate a patient's own stem and regenerative cells in about an hour. This system will dramatically improve the speed in which personalized cell-based therapies can be delivered to patients.
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Nov 3, 2006
Words:226
Previous Article:Embark on an International Adventure with Travelogue 360: Paris Game from Big Fish Games.
Next Article:Jadoo Power Allocated $2.4 Million from 2007 Defense Appropriations Bill.



Related Articles
Cytori Therapeutics Announces Change in Third Quarter Earnings Release and Conference Call Date.
Cytori Therapeutics Announces First Quarter Financial Results: Outlines Significant Development Progress Year to Date.
BREAST RECONSTRUCTION STUDY INITIATED IN JAPAN.
Cytori Announces 2nd Quarter Results; Reports Cardiovascular Clinical Development Plans.
Olympus Expands Investment, Partnership with Cytori Therapeutics in Regenerative Medecine.
Cytori Therapeutics to Present at the AGEdwards Emerging Growth Conference.
Cytori Announces 3rd Quarter Results: Update on Adipose Stem Cells in Cardiac Disease and Reconstructive Surgery.
Cytori to Begin Stem Cell Trial for Heart Disease.
Cytori Reports 2006 Fourth Quarter and Year-End Results; Reviews 2006 Progress and Provides 2007 Outlook.
Cytori Reports First Quarter Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles